interferon
ifn
critic
antivir
activ
immun
regulatori
function
infect
autoimmun
ifn
function
mediat
induc
express
variou
ifnstimul
gene
isg
ifn
divid
three
major
type
type
includ
speci
type
ii
includ
speci
type
iii
includ
speci
type
iii
ifn
identifi
nearli
five
decad
discoveri
type
ifn
type
iii
ifn
similar
induct
mechan
intracellular
signal
pathway
lead
isg
express
howev
use
differ
receptor
encod
distinct
gene
type
iii
ifn
famili
compos
four
member
recent
identifi
among
uniqu
produc
individu
allel
variant
type
iii
ifn
respons
infect
autoimmun
predominantli
observ
epitheli
barrier
includ
gastrointestin
respiratori
tract
earli
antivir
activ
limit
infect
prevent
trigger
system
immun
respons
inflamm
howev
induct
persist
type
iii
ifn
respons
hamper
cellular
respons
type
ifn
particularli
global
around
million
individu
infect
hepat
c
viru
hcv
hcv
singlestrand
positivesens
rna
viru
kb
genom
hcv
encod
structur
protein
includ
core
protein
also
encod
nonstructur
protein
includ
acut
hcv
infect
tend
evolv
chronic
persist
infect
histor
hcv
infect
gener
treat
pegyl
ribavirin
howev
recent
introduct
directact
antivir
daa
target
variou
hcv
nonstructur
protein
patient
treat
without
seriou
advers
effect
high
rate
sustain
virolog
respons
svr
achiev
howev
case
hcv
treatment
ineffect
one
potenti
explan
result
could
presenc
genotyp
subtypespecif
resistanceassoci
substitut
either
preexist
druginduc
hcvinfect
hepatocyt
produc
type
iii
ifn
lead
prolong
upregul
isg
hcvinfect
liver
sever
research
group
includ
shown
hcvinfect
liver
cell
produc
predominantli
type
iii
ifn
furthermor
demonstr
rapidli
produc
hcvinfect
primari
human
hepatocyt
carri
allel
encod
fulli
activ
protein
previou
studi
mainli
focus
either
associ
singl
nucleotid
polymorph
snp
spontan
hcv
clearanc
treatment
respons
genotyp
remain
notabl
daa
era
recent
shown
genotyp
affect
respons
daabas
regimen
among
patient
hcv
review
cover
recent
progress
type
iii
ifn
respons
hepatocyt
role
hcv
infect
focu
open
issu
associ
type
iii
ifn
respons
consid
daa
era
type
iii
ifn
initi
intracellular
signal
autocrin
paracrin
pathway
type
iii
ifn
bind
heterodimer
receptor
includ
type
ifn
receptor
receptor
interleukin
receptor
respect
type
iii
ifn
bind
receptor
intracellular
receptor
subunit
undergo
conform
chang
interact
janu
kinas
jak
lead
activ
jaksign
transduc
activ
transcript
stat
pathway
jak
includ
tyrosin
kinas
bind
type
type
iii
ifn
respect
receptor
complex
lead
phosphoryl
hand
bind
type
ii
ifn
receptor
complex
trigger
phosphoryl
complex
activ
jak
phosphoryl
tyrosin
residu
ifn
receptor
recruit
stat
protein
activ
jakstat
signal
mainli
stimul
format
homodim
directli
bind
dna
altern
type
iii
ifn
mainli
drive
format
heterodim
bind
interferon
regulatori
factor
togeth
protein
form
complex
known
interferonstimul
gene
factor
transloc
nucleu
act
transcript
factor
induc
express
isg
nucleu
homodim
bind
sequenc
ga
dna
bind
interferonstimul
regulatori
element
isr
dna
isg
upstream
regulatori
region
carri
differ
type
statbind
element
includ
solitari
ga
element
solitari
isr
combin
gasisr
element
moreov
divers
bind
site
transcript
factor
activ
regulatori
region
upstream
isg
subtli
shift
allow
express
differ
isg
subset
consequ
upon
ifn
stimul
isg
express
vari
composit
kinet
scale
depend
ifn
induc
signal
cascad
degre
isg
express
differ
significantli
type
iii
ifn
type
ifn
typic
potent
type
iii
ifn
associ
highest
degre
isg
express
follow
decreas
order
studi
isg
express
kinet
shown
type
ifn
stimul
earlier
isg
express
type
iii
ifn
cell
express
recent
studi
forero
colleagu
demonstr
mechan
underli
ifnstimul
express
kinet
immunemodul
effect
highlight
differ
type
ifn
respons
type
iii
ifn
respons
type
ifn
uniqu
activ
transcript
factor
interferon
regulatori
factor
homodim
form
induc
activ
mediat
chemokin
product
recruit
cytotox
lymphocyt
natur
killer
cell
furthermor
forero
colleagu
also
emphas
failur
type
iii
ifn
induc
chemokin
product
due
low
express
level
express
forc
type
iii
ifn
could
induc
chemokin
product
import
antivir
reaction
liver
cell
demonstr
differ
studi
studi
reveal
instant
defens
mechan
virus
initi
seri
isg
basal
transcript
level
isg
reli
constitut
express
although
tyrosin
phosphoryl
critic
stat
activ
unphosphoryl
stat
protein
continu
perform
integr
function
activ
isg
recent
studi
unphosphoryl
stat
ustat
ie
unphosphoryl
tyrosin
residu
observ
nucleu
bound
upstream
regulatori
region
initi
express
set
isg
one
studi
report
stimul
cell
low
concentr
maintain
isg
express
two
three
day
tyrosinephosphoryl
revert
ustat
anoth
report
demonstr
role
unphosphoryl
prolong
isg
induct
type
ifn
treatment
initi
stimul
cell
type
iii
ifn
abund
quantiti
produc
even
without
tyrosin
phosphoryl
protein
combin
form
uniqu
bind
result
express
approxim
isg
upregul
isg
durabl
persist
cell
sever
day
initi
ifn
stimul
major
isg
induc
antivir
activ
could
protect
dna
damag
anoth
recent
studi
demonstr
ifnindepend
baselin
isg
express
mediat
complex
hepatocyt
liver
organoid
liver
tissu
cultur
studi
phosphorylationdefici
mutant
protein
also
activ
noninferior
wildtyp
protein
abil
upregul
isg
confer
antivir
activ
liverderiv
cell
interestingli
mice
homozyg
mutat
show
dramat
reduct
protein
express
find
suggest
initi
ifndepend
signal
play
import
role
express
rapid
induct
isg
type
ii
ifn
absent
phosphorylationdefect
cell
previou
studi
cell
show
gene
express
delay
stimul
type
ifn
intriguingli
phosphoryl
cell
could
also
guid
extend
transcript
respons
resembl
respons
produc
induc
antivir
effect
addit
contribut
format
could
also
bind
constitut
consider
number
ifnactiv
promot
even
absenc
exogen
ifn
stimul
find
corrobor
earlier
studi
demonstr
could
mediat
innat
immun
respons
absenc
excess
ifn
stimul
prevent
close
regul
stat
activ
ubiquitin
carboxytermin
hydrolas
inhibitori
regul
stat
activ
includ
famili
protein
inhibitor
activ
stat
pia
suppressor
cytokin
signal
soc
acid
protein
typic
function
isopeptidas
promptli
induc
viral
infect
ifn
signal
interact
prevent
interact
thu
suppress
signal
transmiss
bind
accord
recent
studi
protein
stabil
maintain
free
intracellular
protein
human
cell
anoth
studi
show
defici
result
increas
viral
resist
human
mous
model
human
could
maintain
stabil
prevent
ubiquitin
must
note
process
independ
isgyl
activ
delsgyl
activ
jakstat
pathway
also
neg
modul
soc
famili
protein
specif
signal
mediat
type
ifn
primarili
suppress
interplay
bind
pia
famili
also
includ
neg
regul
ifn
signal
pia
protein
function
small
ubiquitinlik
modifi
sumo
ligas
interfer
stat
signal
function
phosphoryl
proxim
tyrosin
residu
prevent
piasinduc
sumoyl
result
gener
partial
phosphoryl
stat
dimer
partial
phosphoryl
stat
dimer
neg
affect
jakstat
pathway
activ
compet
fulli
phosphoryl
stat
dimer
ifn
product
isg
upregul
occur
hepatocyt
hcv
infect
although
hcv
interfer
process
figur
product
endogen
ifn
initi
pattern
recognit
receptor
prr
hepatocyt
three
class
prr
retino
acidinduc
genei
rigi
like
receptor
rlr
tolllik
receptor
tlr
nucleotidebind
oligomer
domainlik
receptor
nlr
previou
studi
found
rigi
detect
hcv
untransl
region
utr
howev
recent
studi
found
melanoma
differentiationassoci
protein
rigi
play
central
role
detect
hcv
rna
anoth
studi
demonstr
sequenti
activ
innat
signal
rigi
hcv
infect
bind
rigi
mitochondri
antiviralsign
protein
mav
result
downstream
activ
nuclear
factorkappa
b
recent
evid
suggest
ifn
signal
trigger
hcv
critic
reli
probabl
atpdepend
rna
helicas
known
laboratori
genet
physiolog
protein
probabl
mediat
identif
hcv
rna
cellular
hcv
sens
also
facilit
protein
kinas
r
pkr
pkr
bind
hcv
dsrna
prompt
pkr
activ
mav
trigger
isg
express
ifn
express
isg
upregul
also
induc
recogn
hcv
rna
endosom
recent
studi
mice
lack
canon
signal
show
hepatocyteintrins
critic
amplifi
type
ifn
signal
induc
isg
upregul
recruit
activ
immun
cell
viral
clearanc
mani
ifninduc
long
noncod
rna
lncrna
remain
investig
one
studi
demonstr
hcvinduc
lncrna
stimul
oligomer
activ
enhanc
antivir
respons
hcv
infect
figur
anoth
studi
reveal
antivir
innat
immun
respons
control
lncrna
modul
express
protein
activ
promot
modifi
histon
activ
mediat
lncrna
spatial
domain
notabl
hcv
infect
regul
regardless
whether
jakstat
pathway
activ
gener
virus
evad
ifn
regul
divers
mechan
like
virus
hcv
partial
disrupt
induct
ifn
infect
cell
figur
hcv
proteas
cleav
mav
independ
whether
local
mitochondriaassoci
endoplasm
reticulum
membran
peroxisom
cleavag
mav
hcv
serin
proteas
verifi
analyz
hcvinfect
liver
tissu
interestingli
conserv
mav
mutat
found
nonhuman
primat
prevent
viral
proteas
antagon
result
uncheck
ifn
product
resist
mavsexpress
cell
hcv
also
inhibit
rlrmediat
ifn
product
target
protein
call
stimul
interferon
gene
sting
adaptor
protein
facilit
phosphoryl
tankbind
kinas
howev
mechan
dictat
block
stingmedi
signal
pathway
differ
among
publish
report
ding
et
al
demonstr
disrupt
bind
sting
wherea
nitta
et
al
show
block
interact
mav
sting
third
report
show
genotyp
suppress
accumul
sting
protein
dosedepend
manner
although
exact
mechan
describ
earlier
studi
report
hcv
serin
proteas
cleav
protein
call
receptor
domaincontain
adaptor
induc
trif
downstream
mediat
signal
transduct
howev
recent
observ
could
support
find
recent
studi
found
protein
downregul
trif
protein
level
uniqu
mechan
show
activ
caspas
enhanc
trif
degrad
result
suppress
ifn
signal
proteas
also
degrad
importin
transport
protein
cytoplasm
nucleu
activ
lead
impair
nfkb
traffick
cytoplasm
nucleu
although
hcv
inhibit
ifn
product
infect
hepatocyt
type
iii
ifn
product
persist
hcvinfect
cell
result
express
high
level
liver
chronic
hcv
infect
sever
studi
demonstr
cell
cultur
model
express
higher
level
hcvinfect
cell
figur
later
found
cell
infect
hcv
express
uninfect
cell
near
infect
cell
express
mous
hepatocyt
express
protein
respons
contrast
express
high
level
human
hepatocyt
play
import
role
resist
hcv
viral
infect
gener
function
long
hcv
persist
liver
thu
infect
liver
exhibit
high
express
level
mani
isg
numer
isg
found
play
variou
role
hcv
life
cycl
isg
restrict
viral
spread
induc
variou
type
immun
respons
efficaci
hcv
clearanc
vitro
limit
pattern
express
human
led
interest
use
treat
hepatotrop
viral
infect
consequ
pegyl
develop
treat
hbv
hcv
infect
clinic
trial
evalu
safeti
efficaci
pegyl
treat
hcv
infect
show
promis
result
moreov
advers
effect
associ
therapeut
might
less
sever
associ
type
ifn
fewer
cell
type
express
ifnlr
compar
ifnar
though
express
hepatocyt
clinic
develop
pegyl
therapeut
option
chronic
hcv
infect
termin
upon
discoveri
daa
howev
clinic
studi
pegyl
highlight
safeti
pegyl
rais
possibl
may
use
treat
viral
infect
human
mention
earlier
human
chimpanze
infect
hcv
exhibit
continu
upregul
isg
liver
furthermor
isg
mrna
detect
concurr
hcv
rna
hcvinfect
hepatocyt
despit
continu
upregul
isg
liver
chronic
infect
hcv
exhibit
scant
level
phosphoryl
instead
unphosphoryl
stat
evid
hcvinfect
liver
hcvinfect
cell
induc
express
particular
set
isg
antivir
activ
constitut
sustain
throughout
infect
prolong
isg
express
alway
benefici
spontan
viral
clearanc
svr
induc
treatment
neg
correl
upregul
baselin
isg
studi
group
indic
induc
sustain
upregul
consequ
sustain
exposur
produc
endogen
hcv
infect
unrespons
exogen
therapi
aros
stabil
protein
thu
abund
hcvinfect
liver
explain
patient
elev
baselin
hepat
isg
show
poor
respons
therapi
gene
first
identifi
germlin
dinucleotid
frameshift
variant
exon
gave
rise
express
protein
fulllength
protein
produc
allel
allel
due
prematur
stop
codon
four
type
iii
produc
major
peopl
african
descent
contrast
produc
peopl
european
asian
descent
research
hamper
lack
effici
system
recombin
product
previous
forc
express
allel
fail
produc
signific
amount
protein
mammalian
cell
although
recombin
could
purifi
bacteri
express
system
group
recent
develop
effici
method
recombin
product
introduc
new
nglycosyl
site
protein
found
variant
protein
produc
effici
mammalian
cell
moreov
nglycosyl
display
robust
isginduc
activ
compar
recombin
produc
bacteri
system
sever
studi
report
isg
upregul
primari
human
hepatocyt
phh
cell
could
induc
forc
gene
express
treatment
recombin
protein
display
antivir
activ
hcv
recombin
induc
similar
isg
express
pattern
activ
jakstat
pathway
bind
receptor
group
demonstr
hcv
infect
induc
express
protein
mrna
level
phh
previou
studi
reveal
vivo
vitro
phenotyp
differ
two
variant
compar
variant
haplotyp
variant
display
diminish
vitro
antivir
effect
moreov
recent
genomewid
associ
studi
human
viral
data
caucasian
patient
hcv
genotyp
infect
demonstr
differenti
product
function
impact
viral
load
variabl
viral
amino
acid
variabl
observ
human
leukocyt
antigen
hla
restrict
epitop
throughout
viral
polyprotein
find
support
hypothesi
play
critic
role
control
hcv
infect
despit
antivir
activ
function
neg
impact
hcv
treatment
figur
suboptim
treatment
respons
pegyl
hcv
infect
primarili
associ
allel
previou
studi
demonstr
genotyp
correl
high
intrahepat
isg
level
express
correl
high
liver
level
chronic
hcv
infect
function
impair
form
protein
variant
associ
rel
weak
induct
intrahepat
isg
find
indic
primari
driver
isg
induct
hcvinfect
liver
liver
genotyp
elev
baselin
isg
associ
less
addit
isg
upregul
treat
pegyl
figur
thu
protein
product
liver
might
play
critic
role
upregul
isg
express
chronic
hcv
infect
group
previous
demonstr
protein
level
elev
hcvinfect
liver
found
prolong
stimul
recombin
transfect
gene
induc
robust
sustain
upregul
induct
stabil
protein
led
unrespons
exogen
treatment
figur
thu
allel
hamper
respons
pegyl
treatment
recent
studi
examin
whether
genotyp
modul
isg
express
peripher
blood
mononuclear
cell
pbmc
chronic
hcv
infect
studi
found
isg
express
high
unstimul
pbmc
patient
homozyg
unfavor
variant
find
suggest
genotyp
might
broader
system
effect
hcv
infect
furthermor
genotyp
associ
metabol
alter
associ
hcv
infect
one
studi
show
differ
chang
lowdens
lipoprotein
ldl
level
depend
genotyp
patient
chronic
hepat
c
chc
ldl
level
elev
daa
treatment
patient
chc
achiev
success
svr
subsequ
ldl
level
diminish
patient
carri
gene
patient
carri
gene
similarli
differ
studi
show
genotyp
close
correl
level
sever
type
lipid
includ
total
cholesterol
ldl
apolipoprotein
daa
significantli
improv
treatment
outcom
chronic
hcv
infect
consequ
therapi
longer
use
worldwid
section
describ
daa
treatment
chang
endogen
type
iii
ifn
respons
ifnl
genotyp
affect
outcom
ifnfre
daa
treatment
recent
group
demonstr
vitro
hcvinfect
phh
daa
treatment
abrog
product
includ
restor
respons
exogen
recent
studi
demonstr
daa
treatment
immedi
downregul
isg
express
liver
blood
even
case
prior
ifn
treatment
unsuccess
liver
high
isg
express
find
consist
observ
chimpanze
model
hcv
infect
show
administr
antagonist
rapidli
reduc
isg
level
liver
anoth
recent
studi
character
intrahepat
immun
chang
observ
cure
hcv
daa
therapi
studi
compar
isg
express
nontumor
liver
patient
hcc
treat
without
daa
demonstr
daabas
therapi
viral
clearanc
result
reduc
isg
express
immunecel
profil
similar
two
group
previous
discuss
hcv
infect
erad
endogen
type
iii
ifn
activ
mani
chronic
infect
case
hcv
replic
presenc
elev
isg
level
allel
encod
fulli
activ
correl
upregul
isg
infect
liver
recent
associ
also
observ
genotyp
virolog
relaps
daa
therapi
recent
boson
trial
test
patient
infect
hcv
genotyp
treat
sofosbuvir
ribavirin
reveal
genotyp
close
correl
svr
lower
baselin
isg
level
peripher
blood
liver
anoth
recent
analysi
trial
show
polymorph
associ
virolog
relaps
patient
infect
hcv
genotyp
eight
week
sofosbuvir
ledipasvir
treatment
compar
patient
unfavor
tt
genotyp
fewer
patient
genotyp
experienc
viral
relaps
vs
arm
trial
probabl
relaps
sofosbuvir
velpatasvir
voxilaprevir
treatment
fivefold
higher
patient
unfavor
genotyp
ct
tt
compar
patient
favor
genotyp
detect
frequent
peopl
asian
descent
european
descent
thu
asian
individu
might
markedli
low
virolog
relaps
rate
daa
treatment
contrast
recent
report
show
patient
respons
daa
treatment
exhibit
higher
level
intrahepat
isg
baselin
patient
experienc
viral
breakthrough
consist
studi
anoth
studi
report
frequenc
resistanceassoci
substitut
hcv
genotyp
close
correl
presenc
favor
genotyp
high
viral
load
baselin
find
might
explain
genotyp
correl
neg
correl
treatment
respons
daa
regimen
includ
inhibitor
anoth
studi
show
intrahepat
isg
express
treatment
conclus
higher
svr
viral
relaps
base
studi
could
infer
maintain
intrahepat
type
ifn
signal
end
treatment
isg
downregul
might
facilit
hcv
erad
prevent
viral
relaps
daa
treatment
consist
studi
anoth
recent
report
show
daa
plu
ribavirin
treatment
upregul
express
one
isg
call
tripartit
motifcontain
observ
express
higher
patient
achiev
svr
compar
untreat
patient
futur
research
investig
precis
role
genotyp
determin
treatment
respons
daa
regimen
daa
therapi
also
rapidli
restor
activ
type
ifn
respons
pbmc
assess
term
isg
express
level
phosphoryl
recent
studi
group
demonstr
pretreat
isg
activ
pbmc
might
due
type
ifn
activ
jakstat
signal
anoth
recent
studi
demonstr
two
four
week
start
daa
treatment
isg
downregul
pbmc
end
treatment
rel
elev
baselin
isg
level
interestingli
serum
level
chemokin
increas
concurr
reduct
isg
level
cytokin
show
behavior
anoth
studi
among
patient
acut
hcv
infect
isg
downregul
pbmc
daa
therapi
therapi
isg
level
increas
patient
relaps
patient
achiev
svr
patient
hcv
infect
baselin
isg
level
pbmc
affect
genotyp
furthermor
unfavor
genotyp
encount
frequent
hcv
infect
patient
cryoglobulinem
vascul
metabol
extrahepat
symptom
find
suggest
daa
therapi
might
allevi
hcvinduc
extrahepat
symptom
downregul
extrahepat
isg
worldwid
daa
remain
either
unavail
costprohibit
consider
proport
popul
patient
hcv
infect
develop
countri
moreov
although
daa
highli
effect
hcv
clear
difficulttotreat
patient
understand
hcvinduc
ifn
respons
daa
era
might
facilit
develop
strategi
provid
daa
access
easilyadminist
understand
might
also
contribut
develop
novel
hosttarget
agent
combin
daa
numer
aspect
virusinduc
ifn
induct
jakstat
pathway
activ
remain
address
hcv
rna
virus
tend
employ
multipl
strategi
evad
ifn
respons
need
comprehens
understand
viral
strategi
block
viral
persist
understand
downstream
ifn
signal
need
clarif
associ
hcvinduc
canon
noncanon
jakstat
pathway
moreov
differenti
role
type
iii
ifn
respons
hcvinfect
hepatocyt
clarifi
clarifi
hepatocytespecif
immun
respons
hcv
infect
associ
host
genotyp
may
help
research
understand
initi
defens
mechan
rna
virus
final
seem
impact
respons
treatment
respons
daa
treatment
featur
studi
extend
type
viral
infect
